Chronic stable angina pectoris) is a common manifestation of coronary artery disease (CAD), which affects as many as 112 million people worldwide.Load more
Chronic stable angina pectoris) is a common manifestation of coronary artery disease (CAD), which affects as many as 112 million people worldwide.
Current guidelines recommend pharmacological therapy with first line drugs (beta-blockers, calcium channel blockers, short-acting nitrates). If patients have contraindications to first-line agents, do not tolerate them or remain symptomatic, then introduce second-line drugs (long-acting nitrates, ivabradine, nicorandil, ranolazine and trimetazidine).Load Less
Kevin Cheng, Paul Sainsbury, Michael Fisher, et alEuropean Cardiology Review 2016;11 (2):69–76DOI: https://doi.org/10.15420/ecr.2016:26:1
Ivan Milinkovic, Giuseppe Rosano, Yury Lopatin, et alCardiac Failure Review, 2016;2(2):123–9DOI: https://doi.org/10.15420/cfr.2016:13:1
Tim P van de Hoef, Werner Mohl, Ahmed A Khattab, et alInterventional Cardiology 2011;6(2):186-9DOI: https://doi.org/10.15420/icr.2011.6.2.186